Competition & Peer Data API & CSV Delivery Connect to AI Assistant via MCP

Lakeside Holding Ltd's Competitiveness

A competitive positioning analysis and financial ratio benchmarking of Lakeside Holding Ltd (LSH) against its publicly traded competitors: sales growth, net income, profitability, valuation and market share, plus each peer's market capitalization, revenue, income and employees. Free below: the top 5 peers. Subscriber access adds the full competitor list and CSV downloads.

Peer Data As of Q4 2026
Competitors Tracked
-
Publicly traded peers
Peer Group Market Share
100.00 %
vs 100.00 % a year ago
Revenue Growth Y/Y
-88.24 %
Q4 2026
Net Margin
-900.66 %
Q4 2026

Key Findings: Lakeside Holding Ltd vs Its Competitors

  • TTM: Trailing 12-month revenue of 14M vs -M combined for tracked competitors (100.0% combined share).
  • Trending: Latest-quarter revenue run-rate is decelerating (-78.4% annualized vs trailing 12 months).
  • Peer revenue share: Lakeside Holding Ltd accounted for 100.0% of combined revenue among its tracked peer group, up from 100.0% a year earlier.

Every figure above is sourced and cited in detail further down this page (Market Structure, Profitability & Cost Structure, Productivity vs Peers).

LSH Sales vs. its Competitors, Q4 2026

Lakeside Holding Ltd generated 100.00 % of the combined sales of its peer group, up from 100.00 % a year earlier.

API endpoints for this dataset
https://api.csimarket.com/api/v1/companies/LSH/competitors
https://api.csimarket.com/api/v1/companies/LSH/relationships
https://api.csimarket.com/api/v1/companies/LSH/similar
Programmatic access for models, analytics, and integration workflows.

For context: the Marine Transportation industry grew revenue 2.3% year over year, combined, vs -88.2% for Lakeside Holding Ltd. Lakeside Holding Ltd's share of combined industry revenue moved from 0.01% to 0.00%, a loss of 0.01 percentage points.

Lakeside Holding Ltd's Competitor Quality Breadth

Share of each group, trailing 12 months: profitable (net margin > 0), expanding (revenue growth > 0), growing faster than the industry's own median, and financially distressed (Piotroski F-Score of 2 or below).

Entity Profitable Expanding Above Industry Growth Distressed
Lakeside Holding Ltd No No No No
Similar Growth & Profitability (8) 12.50 % (1 of 8) 25.00 % (2 of 8) 25.00 % (2 of 8) 75.00 % (6 of 8)

Source: CSIMarket API, trailing 12 months. Altman Z-Score is not shown here: it is not populated in the underlying data for any company. Percentages are of companies in each group that report the relevant metric, not of the full group size.

Market Share of the Peer Group, Q4 2026

100%market share
  • Lakeside Holding Ltd100.0%
  • Competitors combined0.0%

Share of combined quarterly revenue of Lakeside Holding Ltd and its 0 tracked competitors.

See Lakeside Holding Ltd's full market share breakdown »

LSH Stock Performance relative to its Competitors

LSH Competitors (weighted) Percent change over the selected range

LSH Stock Performance relative to Similar Growth & Profitability Competitors

LSH Similar Growth & Profitability Competitors (equal-weighted, 8) Percent change over the selected range

Lakeside Holding Ltd's Comment on Competition and Industry Peers

The pharmaceutical distribution industry in China comprises national and regional distributors, wholesalers, specialized distribution and logistics service providers, and other companies offering similar products or services. Competition is influenced by factors such as product availability and range, pricing, supplier and customer relationships, access to healthcare institutions, geographic coverage, procurement and bidding capabilities, logistics and fulfillment capabilities, regulatory qualifications, financial resources, service quality, and reputation. Some competitors possess greater financial resources, wider distribution networks, stronger purchasing power, or more established supplier and customer relationships. The company's competitive position relies on maintaining supplier and customer relationships, securing appropriate products on commercially acceptable terms, delivering reliable services, and adapting to market demand and healthcare policies.